Efficiency of Gamma Probe and Dual-Phase Tc-99m Sestamibi Scintigraphy in Surgery for Patients with Primary Hyperparathyroidism

Clinical Nuclear Medicine

Volumn 28, Issue 3, 2003, Pages 186-191

  Demirkurek, Cengiz H ^a,b   Adalet, Isik ^a   Terzioglu, Tarik ^a   Ozarmagan, Selcuk ^a   Bozbora, Alp ^a   Ozbey, Nese ^a   Kapran, Yersu ^a   Cantez, Sema ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Istanbul Medical Faculty ^*  (Turkey)

Author keywords

Dual Phase Tc 99m Sestamibi; Gamma Probe; Hyperparathyroidism

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; GAMMA RADIATION; HISTOPATHOLOGY; HUMAN; MALE; PRIMARY HYPERPARATHYROIDISM; SCINTIGRAPHY; THYROID GLAND; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; HYPERPARATHYROIDISM; METHODOLOGY; MIDDLE AGED; PARATHYROIDECTOMY; PATHOLOGY; PATIENT MONITORING; PREOPERATIVE CARE; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; CHILD; HUMANS; HYPERPARATHYROIDISM; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PARATHYROIDECTOMY; PREOPERATIVE CARE; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 85047692547     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RLU.0000053406.96478.71     Document Type: Article

References (26)

1. Shen W, Sabanci U, Morita ET, et al: Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy. Arch Surg 132:969, 1997.
2. Sinha CK, Hamaker H, Hamaker RC, et al: Utility of preoperative radionuclide scanning for primary hyperparathyroidism. The Laryngoscope 107:753, 1997.
3. Shen W, Duren M, Morita ET, et al: Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg 131:861, 1996.
4. Numerow LM, Morita ET, Clark OH, et al: Persistent/recurrent hyperparathyroidism: a comparison of sestamibi scintigraphy, MRI, and ultrasonography. J Magn Reson Imaging 5:702, 1995.
5. Robertson GS, Johnson PR, Bolia A, et al: Long-term results of unilateral neck exploration for preoperatively localized nonfamilial parathyroid adenomas. Am J Surg 172:311, 1996.
6. Borley NR, Collins RE, O'Doherty M, et al: Tc-99m sestamibi parathyroid localization is accurate enough for scan-directed unilateral neck exploration. Br J Surg 83:989, 1996.
7. Sofferman RA, Nathan MH, Fairbank JT, et al: Preoperative Tc-99m sestamibi imaging: paving the way to minimal-access parathyroid surgery. Arch Otolaryngol Head Neck Surg 122:369, 1996.
8. Sfakianakis GN, Irvin GL, Foss JL, et al: Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med 37:798, 1996.
9. Irvin GL, Prudhomme DL, Deriso GT, et al: A new approach to parathyroidectomy. Ann Surg 219:574, 1994.
10. Casas AT, Burke GJ, Mansberger AR Jr, et al: Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism. Am Surg 60:12, 1994.
11. Wei JP, Burke GJ: Analysis of savings in operative time for primary hyperparathyroidism using localization with technetium-99m-sestamibi scan. Am J Surg 170:489, 1995.
12. Jarhult J, Nordenstrom J, Perbeck L: Reoperation for suspected primary hyperparathyroidism. Br J Surg 80:453, 1993.
13. Coakley AJ, Kettle AG, Wells CP, et al: 99m-Tc-sestamibi: a new agent for parathyroid imaging. Nucl Med Commun 10:302, 1989.
14. Taillefer R, Boucher Y, Potvin C, et al: Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99-m-sestamibi (double phase study). J Nucl Med 33:1801, 1992.
15. Light VL, McHenry CR, Jarjoura D, et al: Prospective comparison of dual-phase technetium-99m-sestamibi and high resolution ultrasonography in the evaluation of abnormal parathyroid glands. Am Surg 62:562, 1996.
16. Mitchell BK, Kinder BK, Cornelius E, et al: Primary hyperparathyroidism: preoperative localization using technetium-sestamibi scanning. J Clin Endocrinol Metab 80:7, 1995.
17. Gulec SA, Moffat FL, Carroll RG: The expanding clinical role for intraoperative gamma probes. Nuclear Medicine Annual 1997, Lippincott-Raven, Philadelphia pp 209-25.
18. Rutgers EJT, Muller SH, Hoefnagel CA: Use of intraoperative probes in surgical oncology. In: Murray IPC, Ell PJ, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. London: Churchill Livingstone, 1998, pp 1025-36.
19. Martinez DA, King DR, Romshe C, et al: Introperative identification of parathyroid gland pathology: a new approach. J Pediatr Surg 30:1306, 1995.
20. Norman J, Chheda H: Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 122:998, 1997.
21. Casara D, Domenico R, Piotto A, et al: 99mTc-MIBI radio-guided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MIBI and ultrasound imaging protocol. Eur J Nucl Med 27:1300, 2000.
22. Casara D, Rubello D, Cauzzo C, et al: 99mTc-MIBI radio-guided minimally invasive parathyroidectomy: experience with patients with normal thyroids and nodular goiters. Thyroid 12:53, 2002.
23. Murphy C, Norman J: The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 126:1023, 1999.
24. Rubello D, Piotto A, Pagetta C, et al: Ectopic parathyroid adenomas located at the carotid bifurcation: the role of pre-operative Tc-99m MIBI scintigraphy and the intraoperative gamma probe procedure in surgical treatment planning. Clin Nucl Med 26:774, 2001.
25. Denham D, Norman J: Cost effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely on surgeon's choice of operative procedure. J Am Coll Surg 186:293, 1998.
26. Casara D, Rubello D, Pelizzo M, et al: Clinical role of 99mTcO4/MIBI scan, ultrasound and intraoperative gamma probe in the performance of unilateral minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 28:1351, 2001.